These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17009617)

  • 1. [The significance of the ovarian arteriolar vasodilatation in pathogenesis of the ovarian hyperstimulation syndrome].
    Vasiljević M; Prorocić M; Tasić L; Stanimirović B; Dikić S; Mandić V; Jeremić D
    Srp Arh Celok Lek; 2006; 134(7-8):344-7. PubMed ID: 17009617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurohormonal and hemodynamic changes in severe cases of the ovarian hyperstimulation syndrome.
    Balasch J; Arroyo V; Fábregues F; Saló J; Jiménez W; Paré JC; Vanrell JA
    Ann Intern Med; 1994 Jul; 121(1):27-33. PubMed ID: 8198344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome.
    Fábregues F; Balasch J; Ginès P; Manau D; Jiménez W; Arroyo V; Creus M; Vanrell JA
    Am J Gastroenterol; 1999 Apr; 94(4):994-9. PubMed ID: 10201472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators.
    Manau D; Balasch J; Arroyo V; Jiménez W; Fábregues F; Casamitjana R; Creus M; Vanrell JA
    J Clin Endocrinol Metab; 1998 May; 83(5):1489-93. PubMed ID: 9589644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ovarian hyperstimulation syndrome (OHS): borderlines between physiology and pathology].
    Piacentino R; Giobbe C; Giannotta MR; Porpiglia M; Minì D; Grio R
    Minerva Ginecol; 1994; 46(7-8):413-6. PubMed ID: 7970077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ovarian hyperstimulation syndrome].
    Putz M; Egarter C; Feichtinger W
    Wien Klin Wochenschr; 1993; 105(24):708-11. PubMed ID: 8116306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatorenal syndrome.
    Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
    Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxycycline inhibits vascular leakage and prevents ovarian hyperstimulation syndrome in a murine model.
    Fainaru O; Hornstein MD; Folkman J
    Fertil Steril; 2009 Nov; 92(5):1701-5. PubMed ID: 18937946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe ovarian hyperstimulation syndrome: role of peripheral vasodilation.
    Balaśch J; Arroyo V; Carmona F; Llach J; Jiménez W; Paré JC; Vanrell JA
    Fertil Steril; 1991 Dec; 56(6):1077-83. PubMed ID: 1743325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiopathology of the renin-angiotensin system in the ovary.
    De Nuccio I; Salvati G; Genovesi G; Paolini P; Marcellini L; Schiavello V; Re M
    Minerva Endocrinol; 1999 Jun; 24(2):77-81. PubMed ID: 10941427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive endothelin plasma levels in severe ovarian hyperstimulation syndrome.
    Balasch J; Arroyo V; Fábregues F; Jiménez W; Saló J; Vanrell JA
    Fertil Steril; 1995 Jul; 64(1):65-8. PubMed ID: 7789582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndrome.
    Balasch J; Fábregues F; Arroyo V
    Hum Reprod; 1998 Oct; 13(1O):2718-30. PubMed ID: 9804220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
    Schrier RW
    Am J Med; 2006 Jul; 119(7 Suppl 1):S47-53. PubMed ID: 16843085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
    Møller S; Henriksen JH
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiopathology of the renin-angiotensin system in the ovary.
    de Nuccio I; Salvati G; Genovesi G; Paolini P; Marcellini L; Schiavello V; Re M
    Panminerva Med; 1998 Mar; 40(1):58-62. PubMed ID: 9573757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights of osmoregulatory system changes in ovarian hyperstimulation syndrome.
    Bili H; Tsolakidis D; Stangou M; Zafrakas M; Pados G; Memmos D; Tarlatzis BC
    Fertil Steril; 2011 Jan; 95(1):304-6. PubMed ID: 20850728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal blood flow alteration after paracentesis in women with ovarian hyperstimulation.
    Maslovitz S; Jaffa A; Eytan O; Wolman I; Many A; Lessing JB; Gamzu R
    Obstet Gynecol; 2004 Aug; 104(2):321-6. PubMed ID: 15292006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation.
    Audibert G; Steinmann G; de Talancé N; Laurens MH; Dao P; Baumann A; Longrois D; Mertes PM
    Anesth Analg; 2009 Jun; 108(6):1922-8. PubMed ID: 19448223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome.
    Fábregues F; Balasch J; Manau D; Jiménez W; Arroyo V; Creus M; Rivera F; Vanrell JA
    Hum Reprod; 1998 Sep; 13(9):2406-10. PubMed ID: 9806258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.